Koninklijke Philips에 대한 매도 수량은 투자자에게 Koninklijke Philips의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Koninklijke Philips (NYSE:PHG) 주식, 공매도 수량 보고

Koninklijke Philips

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (around 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal care products.

Large Cap

News

Movers

Trading Ideas

APTV

BORR

CHKP

MPWR

SMCI

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 슈퍼 마이크로 컴퓨터(NASDAQ:SMCI)의 주식은 독립 감사인인 언스터 &amp; 영(Ernst &amp; Young)의 사임 소식이 전해진 후 44.89% 하락했다. 아거스 리서치(Argus Research)는 매수에서 보유로 등급을 하향 조정했다.

슈퍼 마이크로 및 에스티 로더는 지난주 최악의 성과를 보인 10개 대형주 중 일부 (10월 28일-11월 1일)

Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips NV

Phil-Good Products Inc

BiomX Inc

BiomX Inc Warrants (13/12/2023)

PETS AT HOME GRP UNSP/ADR by Pets at Home Group PLC

Pets at Home Group PLC

PHARMING GROUP NV ORD by Pharming Group NV

Pharming Group

Biotech

General

Philips Enrolls First U.S. Patient In Clinical Trial For Single-Device Laser System To Treat Peripheral Artery Disease, Achieving Milestone In PAD Treatment Innovation

These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares declined 44.89% following the <a href="https://www.benzinga.com//node/41646425" target="_blank" rel="noreferrer noopener">resignation of its independent auditor</a>, Ernst &amp; Young. Argus Research downgraded <a href="https://www.benzinga.com//node/41661361" target="_blank" rel="noreferrer noopener">the stock from Buy to Hold</a>.</li>
<li>Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) stock dipped 23.69% after it reported first-quarter earnings, and several analysts lowered <a href="https://www.benzinga.com//node/41653721" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Aptiv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) shares fell 18.67% following a <a href="https://www.benzinga.com//node/41657841" target="_blank" rel="noreferrer noopener">third-quarter revenue miss</a>.</li>
<li>SharkNinja (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) shares tumbled 18.48% after it reported <a href="https://www.benzinga.com//node/41648658" target="_blank" rel="noreferrer noopener">third-quarter financial results</a>.</li>
<li>Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) dipped 17.70% last week after reporting worse-than-expected sales results, and analysts <a href="https://www.benzinga.com//node/41637268" target="_blank" rel="noreferrer noopener">revised the price forecast and rating</a>.</li>
<li>Koninklijke Philips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) lost 16.36% after the company <a href="https://www.benzinga.com//node/41570381" target="_blank" rel="noreferrer noopener">reported a Q3 earnings miss</a> and revised annual outlook due to weak demand in China.</li>
<li>Monolithic Power Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>) shares fell 15.75% after the company <a href="https://www.benzinga.com//node/41635566" target="_blank" rel="noreferrer noopener">reported Q3 financial results</a>.</li>
<li>CDW (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDW#NASDAQ">CDW</a>) stock fell 13.19% last week. It reported weaker-than-expected <a href="https://www.benzinga.com//node/41630458" target="_blank" rel="noreferrer noopener">third-quarter earnings</a> amid weak hardware demand and customer delays.</li>
<li>Borr Drilling Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>) lost 13.19% on continued weakness following preliminary Q3 financial results. As of 31 December 2024, the company&#8217;s stock will also be voluntarily delisted from the Oslo Stock Exchange.</li>
<li>Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) stock decreased 12.96% after the company reported quarterly <a href="https://www.benzinga.com//node/41683552" target="_blank" rel="noreferrer noopener">results and October deliveries</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/41702042/reddit-roblox-and-garmin-are-among-top-10-large-cap-gainers-last-week-oct-28-nov-1-are-the-others-" target="_blank" rel="noreferrer noopener">Reddit, Roblox And Garmin Are Among Top 10 Large Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

Super Micro Computer, Li Auto And Estee Lauder Are Among Top 10 Large Cap Losers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?

Industry leaders collaborate to offer Philips clinically proven tools and resources to Aspen Dental patients, providing better care for more people

Philips Partners With Aspen Dental To Launch Multi-Year Sonicare-Brand Partnership

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Citigroup analyst Renata Cabral upgraded the rating for Coca-Cola FEMSA, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOF#NYSE">KOF</a>) from Neutral to Buy and raised the price target from $93 to $102. Coca-Cola Femsa shares closed at $84.40 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Janney Montgomery Scott analyst Sean Milligan upgraded the rating for First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) from Neutral to Buy and announced a $260 price target. First Solar shares closed at $205.03 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Julien Dormois upgraded Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) from Underperform to Hold. Philips shares closed at $26.62 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James analyst Steven Seedhouse upgraded ProQR Therapeutics N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRQR#NASDAQ">PRQR</a>) from Outperform to Strong Buy and boosted the price target from $6 to $14. ProQR Therapeutics shares closed at $3.31 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Adam Seiden upgraded the rating for Summit Materials, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUM#NYSE">SUM</a>) from Equal-Weight to Overweight and raised the price target from $45 to $52. Summit Materials shares closed at $45.63 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying FSLR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="534" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29094905/image-301-1024x534.png" alt="" class="wp-image-619521" style="width:617px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29094905/image-301-1024x534.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29094905/image-301-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29094905/image-301-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29094905/image-301.png 1217w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41598310/jim-cramer-avoid-this-consumer-cyclical-stock-buy-lam-research">Jim Cramer: &#8216;Avoid&#8217; This Consumer Cyclical Stock, Buy Lam Research</a></li>
</ul>

Upgrades

Markets

Analyst Ratings

FSLR

PRQR

This First Solar Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Jefferies analyst Julien Dormois upgrades Koninklijke Philips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) from Underperform to Hold.

Jefferies Upgrades Koninklijke Philips to Hold

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Monday.
U.S. stocks settled higher on Monday, with the Dow Jones index surging more than 250 points ahead of earnings from megacap technology companies.
Both the Dow Jones and S&amp;P 500 ended a six-week winning streak, falling around 1% and 2.7%, respectively. The Nasdaq recorded gains for the seventh straight week, gaining nearly 0.2% last week.
Shares of Koninklijke Philips NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) tumbled around 16% on Monday after the company reported weak third-quarter earnings results.
On the economic data front, the Federal Reserve Bank of Dallas' general business activity index for manufacturing in Texas rose to -3 in October compared to a reading of -9 in September.
Most sectors on the S&amp;P 500 closed on a positive note, with financials, materials, and utilities stocks recording the biggest gains on Monday. However, information technology and energy stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 273 points to 42,387.57 on Monday. The S&amp;P 500 rose 0.27% to 5,823.52, while the Nasdaq Composite climbed 0.26% to close at 18,567.19 during Monday's session.
Investors are awaiting earnings results from Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>), and McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 61.7, the index remained in the &#8220;Greed&#8221; zone on Monday, versus a prior reading of 60.8.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41574887/top-3-industrials-care-stocks-that-plunge-this-month">Top 3 Industrials Care Stocks That Plunge This Month</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Pre-Market Outlook

GOOG

GOOGL

Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 300 points on Monday.
The Dow traded up 0.77% to 42,440.12 while the NASDAQ rose 0.46% to 18,603.67. The S&amp;P 500 also rose, gaining, 0.43% to 5,832.99.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/10/41573022/how-to-earn-500-a-month-from-ford-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Ford Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Financials shares rose by 1.2% on Monday.
In trading on Monday, energy shares fell by 0.7%.
Top Headline
Koninklijke Philips NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) reported third-quarter adjusted EPS of 0.32 euros (or $0.35), missing the consensus of 0.35 euros. The Dutch conglomerate reported sales of 4.38 billion euros ($4.74 billion), down 2% year over year and missing the consensus of 4.54 billion euros.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Healthcare Triangle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares shot up 106% to $1.19 &nbsp;after the company disclosed in a filing that it acquired the business, assets, and operations relating to cloud and technology domain of Securekloud Technologies.</li>
<li>Shares of Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) got a boost, surging 70% to $13.08 &nbsp;after the company reported preliminary results from its clinical trial of RF Ablation technology where 100% of its responder group was able to eliminate opioid use and reduce pain scores.</li>
<li>Evoke Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares were also up, gaining 52% to $7.78 after the company announced the presentation of GLP-1 data for users with diabetic gastoparesis using GIMOTI and showed statistically significant improvements.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) shares dropped 16% to $26.52 after the company reported third-quarter EPS and sales below estimates and revised its 2024 outlook due to weak demand in China.</li>
<li>Shares of Borr Drilling Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>) were down 7% to $4.38. The stock may be moving on continued weakness following Friday&#8217;s reported preliminary third-quarter financial results.</li>
<li>CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) was down, falling 9% to $5.46 following weak quarterly results.</li>
</ul>
Commodities In commodity news, oil traded down 6% to $67.49 while gold traded down 0.1% at $2,754.40.
Silver traded up 0.2% to $33.850 on Monday, while copper fell 0.1% to $4.3655.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 gained 0.41%, Germany's DAX rose 0.35% and France's CAC 40 rose 0.79%. Spain's IBEX 35 Index rose 0.77%, while London's FTSE 100 rose 0.45%.
Retail sales in Spain rose by 4.1% year-over-year in September, while retail sales volumes in the UK fell by 6% in October following a 4% increase in September.
Asia Pacific Markets
Asian markets closed higher on Monday, with Japan's Nikkei 225 gaining 1.82%, Hong Kong's Hang Seng Index gaining 0.05%, China's Shanghai Composite Index gaining 0.68% and India's BSE Sensex surging 0.76%.
Hong Kong&#8217;s trade deficit shrank to $53.2 billion in September from $64.6 billion in the year-ago month.
Economics
The Federal Reserve Bank of Dallas&#8217; general business activity index for manufacturing in Texas rose to -3 in October compared to a reading of -9 in the earlier month.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41570746/top-3-real-estate-stocks-that-may-surge-in-q4">Top 3 Real Estate Stocks That May Surge In Q4</a></li>
</ul>

Equities

Eurozone

Commodities

AMIX

EVOK

HCTI

S&P 500 Moves Higher; Philips Shares Plunge After Q3 Earnings

<h3>Gainers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock rose 124.5% to $1.3 during Monday's regular session. The market value of their outstanding shares is at $7.3 million. </li>
<li>Monte Rosa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLUE#NASDAQ">GLUE</a>) shares increased by 117.99% to $10.66. The market value of their outstanding shares is at $654.2 million. </li>
<li>Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares rose 69.81% to $9.0. The company's market cap stands at $6.6 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares moved upwards by 44.51% to $6.72. The company's market cap stands at $87.4 million. </li>
<li>EyePoint Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) shares moved upwards by 36.31% to $12.95. The market value of their outstanding shares is at $693.0 million. </li>
<li>Genprex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNPX#NASDAQ">GNPX</a>) shares increased by 30.8% to $2.59. The company's market cap stands at $6.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) shares fell 18.3% to $4.91 during Monday's regular session. The company's market cap stands at $25.5 million. </li>
<li>Koninklijke Philips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) stock decreased by 15.92% to $26.63. The market value of their outstanding shares is at $24.8 billion. The company's, Q3 earnings came out today. </li>
<li>Tevogen Bio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) stock declined by 14.11% to $2.62. The company's market cap stands at $447.0 million. </li>
<li>Iterum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRM#NASDAQ">ITRM</a>) shares decreased by 13.83% to $1.62. The market value of their outstanding shares is at $36.7 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) stock fell 12.85% to $0.73. The company's market cap stands at $1.4 million. </li>
<li>Aptorum Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APM#NASDAQ">APM</a>) shares declined by 12.73% to $1.44. The market value of their outstanding shares is at $7.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CYCC

EYPT

GLUE

GNPX

ITRM

SONN

TVGN

12 Health Care Stocks Moving In Monday's Intraday Session

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Monday.
The Dow traded up 0.52% to 42,333.84 while the NASDAQ rose 0.43% to 18,598.02. The S&amp;P 500 also rose, gaining, 0.31% to 5,826.12.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/10/41573022/how-to-earn-500-a-month-from-ford-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Ford Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Utilities shares rose by 1.1% on Monday.
In trading on Monday, energy shares fell by 1%.
Top Headline
ON Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) posted better-than-expected earnings for the third quarter on Monday.
The company posted a revenue decline of 19.2% year-on-year to $1.76 billion, beating the analyst consensus estimate of $1.75 billion. The adjusted EPS of 99 cents beat the analyst consensus estimate of 97 cents.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Healthcare Triangle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares shot up 159% to $1.50 after the company disclosed in a filing that it acquired the business, assets, and operations relating to cloud and technology domain of Securekloud Technologies.</li>
<li>Shares of Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) got a boost, surging 78% to $13.73 after the company reported preliminary results from its clinical trial of RF Ablation technology where 100% of its responder group was able to eliminate opioid use and reduce pain scores.</li>
<li>Evoke Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares were also up, gaining 82% to $9.34 after the company announced the presentation of GLP-1 data for users with diabetic gastoparesis using GIMOTI and showed statistically significant improvements.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) shares dropped 17% to $26.16 after the company reported third-quarter EPS and sales below estimates and revised its 2024 outlook due to weak demand in China.</li>
<li>Shares of Borr Drilling Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>) were down 11% to $4.1987. The stock may be moving on continued weakness following Friday&#8217;s reported preliminary third-quarter financial results.</li>
<li>CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) was down, falling 10% to $5.36 following weak quarterly results.</li>
</ul>
Commodities In commodity news, oil traded down 5.4% to $67.88 while gold traded up 0.1% at $2,755.50.
Silver traded up 0.3% to $33.890 on Monday, while copper fell 0.1% to $4.3660.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.10%, Germany's DAX fell 0.02% and France's CAC 40 rose 0.39%. Spain's IBEX 35 Index rose 0.37%, while London's FTSE 100 rose 0.16%.
Retail sales in Spain rose by 4.1% year-over-year in September, while retail sales volumes in the UK fell by 6% in October following a 4% increase in September.
Asia Pacific Markets
Asian markets closed higher on Monday, with Japan's Nikkei 225 gaining 1.82%, Hong Kong's Hang Seng Index gaining 0.05%, China's Shanghai Composite Index gaining 0.68% and India's BSE Sensex surging 0.76%.
Hong Kong&#8217;s trade deficit shrank to $53.2 billion in September from $64.6 billion in the year-ago month.
Economics
The Federal Reserve Bank of Dallas&#8217; general business activity index for manufacturing in Texas rose to -3 in October compared to a reading of -9 in the earlier month. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41570746/top-3-real-estate-stocks-that-may-surge-in-q4">Top 3 Real Estate Stocks That May Surge In Q4</a></li>
</ul>

Intraday Update

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Monday.
Shares of Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) fell sharply in today's pre-market trading after the company reported third-quarter EPS and sales below estimates and revised its 2024 outlook due to <a href="https://www.benzinga.com/news/earnings/24/10/41570381/dutch-health-tech-firm-philips-q3-earnings-miss-expectations-lowers-annual-forecasts-on-weak-demand">weak demand in China</a>.
On Monday, the company reported third-quarter adjusted EPS of 0.32 euros (or $0.35), missing the consensus of 0.35 euros. The Dutch conglomerate reported sales of 4.38 billion euros ($4.74 billion), down 2% year over year and missing the consensus of 4.54 billion euros.
Koninklijke Philips shares dipped 17.2% to $26.24 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Tevogen Bio Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) shares declined 10.8% to $2.72 after surging 19% on Friday.</li>
<li>Borr Drilling Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>) dipped 6.8% to $4.38 in pre-market trading. Borr Drilling announced pricing of offering of additional 10.375% senior secured notes due 2030 for gross proceeds of $175 million.</li>
<li>Bowhead Specialty Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOW#NYSE">BOW</a>) shares fell 5.6% to $27.77 in pre-market trading. Bowhead Specialty priced its 4 million common share secondary offering at $29 per share.</li>
<li>W&amp;T Offshore, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) shares fell 5.6% to $2.03 in pre-market trading.</li>
<li>Clear Channel Outdoor Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCO#NYSE">CCO</a>) fell 4.3% to $1.5500 in pre-market trading. Clear Channel Outdoor announced the termination of agreement to sell its business in Spain to a subsidiary of JCDecaux following regulatory review.</li>
<li>Obsidian Energy Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OBE#NYSE">OBE</a>) fell 2.9% to $5.74 in pre-market trading. OBSIDIAN ENERGY will release third quarter 2024 financial and operational results before the markets open on Thursday, Oct. 31.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41545103/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-delivering-high-dividend">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields</a></li>
</ul>

Philips Posts Weak Earnings, Joins Clear Channel Outdoor And Other Big Stocks Moving Lower In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) stock increased by 128.3% to $12.1 during Monday's pre-market session. The market value of their outstanding shares is at $8.8 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock moved upwards by 93.43% to $1.12. The market value of their outstanding shares is at $6.3 million. </li>
<li>Monte Rosa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLUE#NASDAQ">GLUE</a>) shares rose 30.47% to $6.38. The market value of their outstanding shares is at $391.5 million. </li>
<li>Revance Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVNC#NASDAQ">RVNC</a>) stock increased by 21.06% to $5.69. The company's market cap stands at $592.7 million. </li>
<li>PROCEPT BioRobotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCT#NASDAQ">PRCT</a>) stock moved upwards by 14.87% to $79.0. The company's market cap stands at $4.1 billion. The company's, Q3 earnings came out today. </li>
<li>Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) stock rose 14.26% to $16.5. The company's market cap stands at $17.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Koninklijke Philips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) stock decreased by 16.9% to $26.31 during Monday's pre-market session. The market value of their outstanding shares is at $24.5 billion. The company's, Q3 earnings came out today. </li>
<li>Monopar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNPR#NASDAQ">MNPR</a>) stock decreased by 12.88% to $14.75. The company's market cap stands at $51.9 million. </li>
<li>Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) shares declined by 10.84% to $0.36. The market value of their outstanding shares is at $19.8 million. </li>
<li>Aclaris Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRS#NASDAQ">ACRS</a>) stock declined by 8.29% to $1.55. The company's market cap stands at $110.5 million. </li>
<li>Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) shares decreased by 7.94% to $0.37. The company's market cap stands at $26.4 million. </li>
<li>Mobile-health Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) shares decreased by 7.92% to $0.44. The company's market cap stands at $14.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACRS

AVTX

MNDR

MNPR

MRNS

PRCT

RVNC

XAIR

12 Health Care Stocks Moving In Monday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock increased by 93.4% to $1.12 during Monday's pre-market session. The market value of their outstanding shares is at $6.3 million. </li>
<li>Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares rose 71.53% to $9.09. The market value of their outstanding shares is at $6.6 million. </li>
<li>Monte Rosa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLUE#NASDAQ">GLUE</a>) shares moved upwards by 32.1% to $6.46. The market value of their outstanding shares is at $396.4 million. </li>
<li>Aspira Womens Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWH#NASDAQ">AWH</a>) shares moved upwards by 22.27% to $1.18. The company's market cap stands at $18.9 million. </li>
<li>Revance Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVNC#NASDAQ">RVNC</a>) stock rose 21.04% to $5.69. The company's market cap stands at $592.6 million. </li>
<li>Mira Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) stock moved upwards by 15.5% to $1.49. The market value of their outstanding shares is at $22.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Koninklijke Philips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) stock declined by 17.0% to $26.29 during Monday's pre-market session. The market value of their outstanding shares is at $24.5 billion. As per the news, the Q3 earnings report came out today. </li>
<li>Monopar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNPR#NASDAQ">MNPR</a>) stock fell 12.88% to $14.75. The company's market cap stands at $51.9 million. </li>
<li>Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) stock decreased by 10.84% to $0.36. The market value of their outstanding shares is at $19.8 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) stock declined by 9.84% to $0.32. The company's market cap stands at $4.7 million. </li>
<li>Aclaris Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRS#NASDAQ">ACRS</a>) shares declined by 8.88% to $1.54. The market value of their outstanding shares is at $109.8 million. </li>
<li>Mobile-health Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) stock decreased by 8.06% to $0.44. The market value of their outstanding shares is at $14.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ENSC

MIRA

On Monday, Koninklijke Philips NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) reported third-quarter adjusted EPS of 0.32 euros (or $0.35), missing the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of 0.35 euros</a>.
&#8220;In the quarter, demand from hospitals and consumers in China further deteriorated, while we continue to see solid growth in other regions. We have adjusted our full-year sales outlook to reflect the continued impact from China,&#8221; said Roy Jakobs, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41566641/philips-delivers-strong-margin-improvement-flat-comparable-sales-due-to-further-deteriorated-deman" rel="noreferrer noopener">CEO of Royal Philips</a>.
&#8220;Within a challenging macro environment, we remain focused on successfully executing our three-year plan to fully capture growth and margin expansion opportunities,&#8221; Jakobs added.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/large-cap/24/10/41172015/philips-issues-software-fix-for-some-ventilators-to-fix-power-alarms-issues-oxygen-display-errors" rel="noreferrer noopener">Philips Issues Software Fix For Some Ventilators To Fix Power Alarms Issues, Oxygen Display Errors</a>.
The Dutch conglomerate reported sales of 4.38 billion euros ($4.74 billion), down 2% year over year and missing the consensus of 4.54 billion euros.
Group comparable sales were flat on the back of 11% growth in the quarter and a deterioration in demand in China.
The company delivered growth in all other regions and from increased royalty income. China remains a fundamentally attractive growth market for Philips in the long term, with market conditions expected to remain uncertain.
Comparable order intake in the quarter declined 2% due to China, with solid order intake growth in Diagnosis &amp; Treatment, particularly in the U.S. Year-to-date comparable order intake grew 1%, including China.
Diagnosis &amp; Treatment comparable sales decreased 1%, on the back of 14% growth in&nbsp;the third quarter&nbsp;of 2023, with solid growth outside of China.
Connected Care comparable sales were flat, with growth in Enterprise Informatics and Sleep &amp; Respiratory Care offset by a low-single-digit decline in Monitoring on the back of high-teens growth the prior year.
Personal Health comparable sales decreased 5% due to a double-digit decline in China, more than offsetting a robust performance elsewhere.
Guidance: The Dutch health technology expects full-year 2024 comparable sales growth of 0.5%-1.5% versus the <a target="_blank" href="https://www.benzinga.com/news/earnings/24/07/40008191/philips-backs-annual-guidance-on-higher-q2-earnings-despite-china-weakness" rel="noreferrer noopener">prior guidance of 3%-5%</a>.
Philips expects comparable sales growth outside of China to remain within the 3-5% range.
The adjusted EBITA margin is expected to be around 11.5%, at the upper end of the range, and free cashflow around EUR 0.9 billion, at the lower end of the range.
Price Action: PHG stock is down 17.1% at $26.25 during the premarket session at last check Monday.
Photo by Mats Wiklund via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41562048/leonardo-dicaprio-backs-harris-says-trump-continues-to-deny-the-facts-on-climate" target="_blank" rel="noreferrer noopener">Leonardo DiCaprio Backs Harris, Says Trump &#8216;Continues To Deny The Facts&#8217; On Climate</a>.</li>
</ul>

Guidance

Health Care

Dutch Health Tech Firm Philips' Q3 Earnings Miss Expectations, Lowers Annual Forecasts On Weak Demand In China

WIIM

Philips shares are trading lower after the company reported Q3 EPS and sales below estimates and revised its 2024 outlook due to weak demand in China.

Shares of LENZ Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LENZ#NASDAQ">LENZ</a>) rose sharply in <a href="https://www.benzinga.com/quote/LENZ">today's pre-market trading</a>.
CORXEL and LENZ Therapeutics revealed topline data from China Phase 3 Presbyopia trial of LNZ100.
LENZ Therapeutics shares jumped 18% to $31.88 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Healthcare Triangle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) rose 121% to $1.28 in pre-market trading. The Healthcare Triangle announced it acquired substantially all of the business, assets, and operations relating to cloud and technology domain of Securekloud Technologies on Oct. 21.</li>
<li>Pixie Dust Technologies, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXDT#NASDAQ">PXDT</a>) gained 109% to $1.40 in pre-market trading. Pixie Dust Technologies shares dipped 36% on Friday after the company recently announced it will delist its ADR units from the Nasdaq Capital Market and submit a deregistration application with the SEC.</li>
<li>Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) shares rose 24.6% to $0.0847 in pre-market trading after falling 16% on Friday. Jet.AI announced the pricing of $1.5 million registered direct offering of 15.6 million shares of common stock at a price of $0.096 per share.</li>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) shares surged 24.5% to $0.6720 in pre-market trading after dipping 96% on Friday.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) shares jumped 19.4% to $1.91 in pre-market trading after dipping 19% on Friday.</li>
<li>Longeveron Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) climbed 19% to $2.63 in pre-market trading. Longeveron shared long-term data on transplant-free survival with Lomecel-B in Hypoplastic Left Heart Syndrome (HLHS) at the 51st Annual Meeting CHSS.</li>
<li>Tarsus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) gained 15.5% to $45.50 in pre-market trading.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) shares rose 11.8% to $5.95 in pre-market trading after jumping 26% on Friday.</li>
<li>ADS-TEC Energy PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSE#NASDAQ">ADSE</a>) shares gained 10.3% to $15.99 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>SMX (Security Matters) Public Limited Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) shares dipped 30% to $0.9739 in pre-market trading after dipping 33% on Friday.</li>
<li>Upexi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPXI#NASDAQ">UPXI</a>) shares fell 21.8% to $6.33 in pre-market trading. Upexi shares jumped 170% on Friday after the company said it is currently reviewing trading activity to determine if recent activity involved possible stock manipulation.</li>
<li>Monopar Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNPR#NASDAQ">MNPR</a>) shares fell 19% to $13.72 in pre-market trading after dipping 48% on Friday. The company recently entered into an agreement with Alexion, AstraZeneca Rare Disease, for an exclusive worldwide license to ALXN-1840 for Wilson disease.</li>
<li>EON Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EONR#NYSE">EONR</a>) fell 16.8% to $1.04 in today's pre-market trading.</li>
<li>ARB IOT Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBB#NASDAQ">ARBB</a>) fell 16.6% to $0.57 in pre-market trading after jumping 107% on Friday.</li>
<li>Jeffs&#8217; Brands Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) fell 16.5% to $0.2821 in pre-market trading after jumping 23% on Friday.</li>
<li>Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) declined 16.1% to $26.58 in pre-market trading after posting downbeat quarterly results.</li>
<li>NWTN Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares declined 13.8% to $0.8090 in pre-market trading after jumping 62% on Friday.</li>
<li>Indonesia Energy Corporation Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDO#NASDAQ">INDO</a>) shares fell 13% to $4.03 after gaining 7% on Friday.</li>
<li>Tevogen Bio Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) fell 9.5% to $2.76 in pre-market trading. Tevogen Bio issued additional guidance on introduction of T Cell therapy for oncology and specialty care therapeutic areas.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41545103/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-delivering-high-dividend">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields</a></li>
</ul>

ADSE

ARBB

EONR

IBRX

INDO

JFBR

JTAI

LENZ

LGVN

NWTN

PXDT

TARS

TCBP

UPXI

Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Koninklijke Philips' Q3 Comparable Sales Were Flat And Comparable Order Intake Decreased By 2%, Both Impacted By Weaker Demand In China

Outlook
The significant deterioration in China demand leads to an updated comparable sales growth outlook range of 0.5-1.5% for the full year 2024. Comparable sales growth outside of China remains within the 3-5% range. Adjusted EBITA margin is expected to be around 11.5%, the upper end of the range, with free cashflow around EUR 0.9 billion, at the lower end of the range.
Within an ongoing challenging macro environment, Philips remains focused on successfully executing its three-year plan to drive operational improvement and create value with sustainable impact. The uncertainties signaled in earlier quarters have intensified in China and are expected to continue.
The outlook excludes the potential impact of the ongoing Philips Respironics-related legal proceedings, including the investigation by the US Department of Justice

Philips Revises 2024 Outlook On Weak China Demand: Now Sees Comparable Sales Growth Of 0.5-1.5%; Non-China Growth Steady At 3-5%, Adjusted EBITA Margin Of 11.5%, And Free Cash Flow Around EUR 0.9 Billion

Koninklijke Philips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) reported quarterly earnings of €0.32 per share which missed the analyst consensus estimate of €0.35 by 8.57 percent. This is unchanged from the same period last year. The company reported quarterly sales of €4.377 billion which missed the analyst consensus estimate of €4.538 billion by 3.55 percent. This is a 10.05 percent decrease over sales of €4.866 billion the same period last year.

Earnings Misses

Koninklijke Philips Q3 2024 Adj. EPS €0.32 Misses €0.35 Estimate, Sales €4.377B Miss €4.538B Estimate

Koninklijke Philips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) is preparing to release its quarterly earnings on Monday, 2024-10-28. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Koninklijke Philips to report an earnings per share (EPS) of $0.38.
The announcement from Koninklijke Philips is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.05, which was followed by a 2.5% drop in the share price the next day.
Here's a look at Koninklijke Philips's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.27</td>
<td>0.28</td>
<td>0.63</td>
<td>0.330</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.32</td>
<td>0.28</td>
<td>0.44</td>
<td>0.359</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-3.0%</td>
<td>-1.0%</td>
<td>-0.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729864865_0.png" alt="eps graph" />
<a href="https://www.benzinga.com/quote/PHG/earnings">To track all earnings releases for Koninklijke Philips visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Look Ahead: Koninklijke Philips's Earnings Forecast

OMNIVISION Partners With Philips To Launch World's First In-Cabin Driver Health Monitoring Solution Featuring CMOS Image Sensor And Vital Signs Monitoring Software; Prototype To Debut At AutoSens Europe In Barcelona

Morgan Stanley lowered the firm's price target on Philips (PHG) to EUR 24.20 from EUR 25 and keeps an Equal Weight rating on the shares. Published ...

Philips price target lowered to EUR 24.20 from EUR 25 at Morgan Stanley

Deutsche Bank lowered the firm's price target on Philips (PHG) to EUR 25 from EUR 27 and keeps a Hold rating on the shares. Published first on TheF...

Philips price target lowered to EUR 25 from EUR 27 at Deutsche Bank

Kepler Capital analyst Oliver Reinberg maintained a Buy rating on Koninklijke Philips N.V. (0LNG – Research Report) on November 1 and set a price t...

Koninklijke Philips N.V. (0LNG) Receives a Buy from Kepler Capital

In a report released today, Richard Felton from Goldman Sachs maintained a Buy rating on Koninklijke Philips N.V. (0LNG – Research Report), with a ...

Goldman Sachs Sticks to Their Buy Rating for Koninklijke Philips N.V. (0LNG)

Goldman Sachs analysts removed Philips (PHG) from the firm's European Conviction List as part of its monthly update. Published first on TheFly – th...

Philips removed from European Conviction List at Goldman Sachs

Royal Philips (PHG) announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study a combined laser atherectomy an...

Philips enrolls first patient in U.S. THOR IDE clinical trial

Artisan International Value Fund Q3 2024 Commentary

Royal Philips (PHG) announced a major advance in radiation oncology with 510(k) clearance from the US Food and Drug Administration for its new dete...

Philips receives FDA 510(k) clearance for Spectral CT 7500 RT

Artisan Value Income Fund Q3 2024 Commentary

Barclays analyst Hassan Al-Wakeel raised the firm's price target on Philips (PHG) to EUR 32 from EUR 30.50 and keeps an Overweight rating on the sh...

Philips price target raised to EUR 32 from EUR 30.50 at Barclays

ACGL

ANCTF

APAM

ARMK

BABA

BABAF

CMPGF

CMPGY

FANG

HXSCF

KRYAF

KRYAY

MCHVF

MCHVY

NTAP

NVSEF

PLXNF

RYLPF

SDXAY

SDXOF

SDZNY

SDZXF

SSNLF

SVNDF

SVNDY

UNLYF

WAFD

Press Releases

OMNIVISION Partners with Philips on Industry's First In-Cabin Driver Health Monitoring Automotive Solution

Philips showcases next level cardiology innovations for improved patient care at TCT 2024

Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments

Philips delivers strong margin improvement; flat comparable sales due to further deteriorated demand in China; growth in rest of world

Philips to Further Roll Out RATE: AI for Early Infection Detection at U.S. Department of Defense Through Four-Year, $25 Million Contract

Philips and Aspen Dental launch multi-year Sonicare-brand partnership

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

Philips Spectral CT 7500 RT, world's first spectral 4DCT respiratory-gated imaging receives FDA 510(k) clearance

Philips Norelco and actor Adam Scott pay tribute to "The King of Beards" this holiday

Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24

Comments

Koninklijke Philips

매도 수량

Koninklijke Philips (NYSE:PHG) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌